An insight into the public acceptance of nutrigenomic-based personalised nutrition

作者：Fallaize R; Macready A L; Butler L T; Ellis J A; Lovegrove J A^*

来源：Nutrition Research Reviews, 2013, 26(1): 39-48.

DOI：10.1017/S0954422413000024

• Personalised nutrition
• Consumer acceptance
• Disease prevention
• Nutrigenomics

It is predicted that non-communicable diseases will account for over 73% of global mortality in 2020. Given that the majority of these deaths occur in developed countries such as the UK, and that up to 80% of chronic disease could be prevented through improvements in diet and lifestyle, it is imperative that dietary guidelines and disease prevention strategies are reviewed in order to improve their efficacy. Since the completion of the human genome project our understanding of complex interactions between environmental factors such as diet and genes has progressed considerably, as has the potential to individualise diets using dietary, phenotypic and genotypic data. Thus, there is an ambition for dietary interventions to move away from population-based guidance towards %26apos;personalised nutrition%26apos;. The present paper reviews current evidence for the public acceptance of genetic testing and personalised nutrition in disease prevention. Health and clear consumer benefits have been identified as key motivators in the uptake of genetic testing, with individuals reporting personal experience of disease, such as those with specific symptoms, being more willing to undergo genetic testing for the purpose of personalised nutrition. This greater perceived susceptibility to disease may also improve motivation to change behaviour which is a key barrier in the success of any nutrition intervention. Several consumer concerns have been identified in the literature which should be addressed before the introduction of a nutrigenomic-based personalised nutrition service. Future research should focus on the efficacy and implementation of nutrigenomic-based personalised nutrition.

• 出版日期2013-6